Fitness Trends Dermatology Diagnostic Devices and Therapeutics Ma | Page 3

Latest launch and improved products is driving the Dermatology diagnostic devices and
therapeutics market growth
Innovation of new and improved products in the market is expected to keep the market more
competitive to combat with the latest product. For example, new product Dupixent approved by
the U.S. FDA in 2017, is an injectable medication for the adult patients with moderate or acute
eczema. This is mainly for the patients affected by the disease which cannot be controlled with
prescription therapies used on skin (topically). Some of the major players operating in the
global dermatology diagnostic devices and therapeutics market include Agfa-Gevaert N.V.,
Valeant Pharmaceuticals International, Inc., Cutera, Inc., Astellas Pharma, Inc., Galderma S.A.,
Novartis International AG., Dino-Lite Europe/IDCP B.V., Genentech, LEO Pharma A/S, Michelson
Diagnostics Ltd, and Sun Pharmaceutical Industries Ltd.
Ask For Discount Before Purchasing This Business Report @
https://www.coherentmarketinsights.com/insight/request-discount/933
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: [phone]
Email: [e-mail]